Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.500
+0.030 (1.21%)
Nov 21, 2024, 4:00 PM EST - Market closed
Mangoceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 6 | - | - |
| Enterprise Value | 6 | 5 | - | - |
| Last Close Price | 2.47 | 4.15 | - | - |
| PS Ratio | 5.40 | 7.96 | - | - |
| PB Ratio | 0.37 | 7.52 | - | - |
| P/TBV Ratio | - | 7.52 | - | - |
| EV/Sales Ratio | 7.98 | 6.47 | - | - |
| Debt / Equity Ratio | 0.02 | 0.17 | 0.57 | -2.35 |
| Asset Turnover | 0.09 | 0.71 | 0.02 | - |
| Quick Ratio | 0.07 | 3.50 | 2.62 | 0.57 |
| Current Ratio | 0.07 | 3.88 | 2.67 | 0.57 |
| Return on Equity (ROE) | -126.52% | -1326.69% | -669.02% | - |
| Return on Assets (ROA) | -62.88% | -494.04% | -242.68% | - |
| Return on Capital (ROIC) | -67.99% | -542.58% | -251.60% | - |
| Earnings Yield | -154.53% | -158.13% | - | - |
| FCF Yield | -90.01% | -120.17% | - | - |
| Buyback Yield / Dilution | -69.51% | -49.22% | -34.98% | - |
| Total Shareholder Return | -69.51% | -49.22% | -34.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.